Huntington Disease – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Mon, 23 Mar 2020 15:08:04 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Huntington Disease – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? https://www.cannabisclinicians.org/2013/02/01/cannabidiol-for-neurodegenerative-disorders-important-new-clinical-applications-for-this-phytocannabinoid/ Sat, 02 Feb 2013 03:57:13 +0000 https://www.cannabisclinicians.org/?p=14710 Authors: Javier Fernández‐Ruiz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger Pertwee, et al
British Journal of Clinical Pharmacology, February 2013
---
Cannabidiol (CBD) is a phytocannabinoid with therapeutic properties for numerous disorders exerted through molecular mechanisms that are yet to be completely identified. CBD acts in some experimental models as an anti-inflammatory, anticonvulsant, anti-oxidant, anti-emetic, an...

The post Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? appeared first on Society of Cannabis Clinicians.

]]> Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease. https://www.cannabisclinicians.org/2011/01/01/cannabinoid-receptors-and-huntingtons-disease/ Sat, 01 Jan 2011 22:35:48 +0000 http://cannabisclinicians.org/?p=6507 Authors: Cristina Blázquez, Anna Chiarlone, Onintza Sagredo, Tania Aguado, M. Ruth Pazos, et al
Brain, January 2011
---
Endocannabinoids act as neuromodulatory and neuroprotective cues by engaging type 1 cannabinoid receptors. These receptors are highly abundant in the basal ganglia and play a pivotal role in the control of motor behaviour. An early downregulation of type 1 cannabinoid receptor...

The post Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease. appeared first on Society of Cannabis Clinicians.

]]>